LEADER 03589nam  22007572  450 
001 9910790236703321
005 20151005020623.0
010   $a1-139-41099-7
010   $a1-107-22322-9
010   $a1-280-68282-5
010   $a1-139-41303-1
010   $a9786613659767
010   $a1-139-41927-7
010   $a1-139-04796-5
010   $a1-139-42131-X
010   $a1-139-41722-3
010   $a1-139-42336-3
035   $a(CKB)2670000000203836
035   $a(EBL)907088
035   $a(OCoLC)794663459
035   $a(SSID)ssj0000658027
035   $a(PQKBManifestationID)11395698
035   $a(PQKBTitleCode)TC0000658027
035   $a(PQKBWorkID)10681012
035   $a(PQKB)11357501
035   $a(UkCbUP)CR9781139047968
035   $a(MiAaPQ)EBC907088
035   $a(Au-PeEL)EBL907088
035   $a(CaPaEBR)ebr10568370
035   $a(CaONFJC)MIL365976
035   $a(PPN)261285211
035   $a(EXLCZ)992670000000203836
100   $a20110304d2012||||  uy|            0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe politics of blood $eethics, innovation, and the regulation of risk /$fAnne-Maree Farrell$b[electronic resource]
210  1$aCambridge :$cCambridge University Press,$d2012.
215   $a1 online resource (xviii, 264 pages) $cdigital, PDF file(s)
225 1 $aCambridge bioethics and law ;$v17
300   $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
311   $a1-107-47479-5 
311   $a0-521-19318-4 
320   $aIncludes bibliographical references and index.
327   $a1. Introduction; 2. The governance of the blood system; 3. Revisiting the gift relationship; 4. Professional beliefs and scientific expertise; 5. Risk and innovation; 6. The rise of the recipient; 7. The politics of precaution; 8. Regulating risk; 9. Conclusion.
330   $aHow best to manage risk involving multi-valued human biological materials is the overarching theme of this book, which draws on the sourcing and supply of blood as a case study. Blood has ethical, social, scientific and commercial value. This multi-valuing process presents challenges in terms of managing risk, therefore making it ultimately a matter for political responsibility. This is highlighted through an examination of the circumstances that led to HIV blood contamination episodes in the US, England and France, as well as their consequences. The roles of scientific expertise and innovation in managing risks to the blood system are also analysed, as is the increased use of precautionary and legal strategies in the post-HIV blood contamination era. Finally, consideration is given to a range of policy and legal strategies that should underpin effective risk governance involving multi-valued human biological materials.
410  0$aCambridge bioethics and law ;$v17.
606   $aBlood banks$xGovernment policy
606   $aBlood products$xSafety measures
606   $aBlood$xMoral and ethical aspects
606   $aBlood$xSocial measures
615  0$aBlood banks$xGovernment policy.
615  0$aBlood products$xSafety measures.
615  0$aBlood$xMoral and ethical aspects.
615  0$aBlood$xSocial measures.
676   $a362.17/84
686   $aLAW093000$2bisacsh
700   $aFarrell$b Anne-Maree$f1964-$01076051
801  0$bUkCbUP
801  1$bUkCbUP
906   $aBOOK
912   $a9910790236703321
996   $aThe politics of blood$93833146
997   $aUNINA